News & Analysis on Clinical Trial Services & Contract Research And Development
Roche has formed a research collaboration with Epitomics, giving Roche a license to Epitomics' monoclonal antibody technology (RabMab technology) for the discovery and development of monoclonal antibodies to treat cancer and other diseases.
Olympus Microscopes announces the launch of two new microscopy products that aims to further improve live cell imaging conditions that characterises drug development.
Procyon has announced preclinical results for its lead HIV protease inhibitor that has demonstrated cross-resistance profile and multi-drug resistant strains of HIV-1 compared to other HIV protease inhibitors, which are fast becoming ineffective...
Chiron has warned it will yet again fall short of targets for its US flu vaccine deliveries this year due to continuing production problems with its British manufacturing plant.
New Life Scientific and CureLab have identified an anti fungal compound that represents a significant breakthrough as part of a joint collaboration, which has demonstrated immunostimulating and antibacterial properties.
According to a new report, worldwide revenues for cell and cytokine therapies in regenerative medicine are set to reach $20.7 billion (€17.3 billion) in 2010 in a sector that provides a viable alternative to using drugs or other therapies.